Vivani Medical, Inc.

Stage 3 · Topping · week 4

As of Oct 22, 2026, Vivani Medical is in Stage 3, the topping phase, now in week 4 (since Sep 29, 2026). It closed at $1.09, 38.4% below its 52-week high and below its 200-day average, which is falling.

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. More about the company

$1.09

-6.03% today

$98.3M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Topping: the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is VANI early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 17w

S4 20w

S1 14w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S3 1w → S4 12w → S1 4w → S4 8w → S1 3w → S2 12w → S3 10w → S4 17w → S1 7w → S4 20w → S1 6w → S2 11w → S3 3w → S2 8w → S3 9w → S4 11w → S1 14w → S2 6w → S3 3w current

Total tracked: 166 weeks across 19 stage runs.

VANI among Biotechnology297th of 591 by relative strength

All 591 →

Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	GTBPGT Biopharma, Inc.	Stage 2 · wk 7	99	−22.3%
2	IOVAIovance Biotherapeutics, Inc.	Stage 2 · wk 18	99	+38.8%
3	SLSSELLAS Life Sciences Group, Inc.	Stage 3 · wk 4	99	−1.5%
4	MRNAModerna, Inc.	Stage 2 · wk 17	99	+11.3%
5	TWSTTwist Bioscience Corporation	Stage 2 · wk 39	99	−14.5%
6	KODKodiak Sciences Inc	Stage 2 · wk 4	99	+172.1%
7	ERASErasca, Inc.	Stage 3 · wk 5	99	+0.7%
8	CLYMClimb Bio, Inc.	Stage 3 · wk 3	99	−15.8%
…297	VANIVivani Medical, Inc.	Stage 3 · wk 4	31	−11.4%

vs 52W High

-38.4%

$0.94 lo$1.77 hi

38.4% below 52W high, weakening from peak

The stock is rolling over from its 52-week high. In Stage 3 distribution, new long positions carry high risk.

Stage Maturity

Week 4

1w13w26w

Week 4, early distribution

How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.

vs 200 DMA

-13.6%

200 DMA: $1.26 · sloping down

Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.

Rel Volume

1.18x

vs 50-day avg

Volume spikes on down days during Stage 3 signal distribution, with institutions exiting. Stage analysis reads that as a warning against new long positions.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-11.4%

-14.8%

-16.8%

YTD

-14.2%

-35.1%

Scan Membership

Breakout Watch

Latest: 2024-02-29

6 appearances in last 60 days. First seen: 2019-10-30.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S3

Wk 4 · Vol 1.18x

2026-10-21S3

Wk 4 · Vol 0.78x

2026-10-20S3

Wk 4 · Vol 0.44x

2026-10-19S3

Wk 3 · Vol 0.39x

2026-10-16S3

Wk 3 · Vol 1.80x

2026-10-15S3

Wk 3 · Vol 0.54x

2026-10-14S3

Wk 3 · Vol 0.78x

2026-10-13S3

Wk 3 · Vol 1.36x

2026-10-12S3

Wk 2 · Vol 0.75x

2026-10-09S3

Wk 2 · Vol 0.52x

2026-10-08S3

Wk 2 · Vol 1.36x

2026-10-07S3

Wk 2 · Vol 1.43x

Moving averages & range

50 DMA

$1.28

200 DMA

$1.26

52W High

$1.77

52W Low

$0.94

5D Low

$1.09

Resistance levels (recent highs)

20d High

$1.27

60d High

$1.49

120d High

$1.60

250d High

$1.77

Next resistance

+16.5%

to 20d High

ROE

-220.4%

Profit margin 0.0%

Dividend Yield

0.00%

P/B 5.1

Vivani Medical: quick answers

What stage is Vivani Medical in?

As of Oct 22, 2026, Vivani Medical (VANI) is in Stage 3, the topping phase. It entered Stage 3 on Sep 29, 2026 and is in week 4. What the four stages mean

Is Vivani Medical in an uptrend?

Its uptrend has stalled. Vivani Medical is in Stage 3, the topping phase that follows an advance. It trades 13.6% below its 200-day average, which is falling.

How far is Vivani Medical from its 52-week high?

Vivani Medical closed at $1.09 on Oct 22, 2026, 38.4% below its 52-week high of $1.77. Its 52-week low is $0.94.

How has Vivani Medical performed over the past year?

As of Oct 22, 2026, Vivani Medical is down 35.1% over the past year and down 14.2% so far in 2026.

Which sector and industry is Vivani Medical in?

Vivani Medical is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.